The problem with the 'vaxxed and done' convo
Here's the problem with all the recent "vaxxed and done" discourse: While my pandemic may be over, ours isn't.
Like a lot of Americans, I'm vaxxed and boosted, and so is everybody in my household. My son goes to middle school every day and my wife works in a grocery store, so I assume the virus is coming home sooner or later — but I'm not too worried about it. Even as the Omicron variant surges and breakthrough infections rise, vaccinated people are pretty much staying out of the hospital. My family has done what we reasonably can to protect our health and lives. Under "vaxxed and done" logic, we should be free to return to some kind of normal, right?
But things aren't normal in my mid-sized community, and in lots of communities around the United States. My kid is in school, but thousands of his fellow students aren't. (The same is true in New York, where about 70 percent of students are showing up for class.) My favorite coffee shop has reverted to carryout-only service; the baristas were scrambling to find at-home tests to help ensure they were safe to keep serving the public. The same is true of a few other businesses. Most distressingly, the local hospital — like hospitals around the country — is swamped, struggling to keep up with a wave of COVID patients. This is a bad time to have a heart attack or a car wreck.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
I'm fine. But we aren't. And because we aren't, my life can't go entirely back to normal.
That's frustrating for a lot of folks who — having done the right thing and gotten all their shots — are ready to move on. "The medical establishment remains singularly focused on this virus, even as life-saving vaccines have been available to every adult in America who wants them for almost a year now," the writer Bari Weiss grumbled in her latest Substack column. "Meanwhile, other problems go ignored." She's vaxxed, she's done, and she's not entirely wrong.
But if the medical establishment is "singularly focused" on COVID despite the availability of vaccines, that's because there's not much choice. More than 1,700 Americans died of the coronavirus on Tuesday, a 40 percent increase over two weeks ago. Another 140,000 were hospitalized with the virus — an 84 percent increase — and while those hospitalizations might be shorter than in previous waves, that's still an incredible drain on our collective medical resources. A lot of the "vaxxed and done" conversation treats our groaning healthcare system as an afterthought.
I'm not sure how to resolve the tensions between "I'm fine" and "we're not," except to hope the Omicron surge passes quickly. In the meantime, an old truism bears repeating: We may be done with COVID. I certainly am. But it is not done with us yet.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joel Mathis is a writer with 30 years of newspaper and online journalism experience. His work also regularly appears in National Geographic and The Kansas City Star. His awards include best online commentary at the Online News Association and (twice) at the City and Regional Magazine Association.
-
5 hilariously spirited cartoons about the spirit of Christmas
Cartoons Artists take on excuses, pardons, and more
By The Week US Published
-
Inside the house of Assad
The Explainer Bashar al-Assad and his father, Hafez, ruled Syria for more than half a century but how did one family achieve and maintain power?
By The Week UK Published
-
Sudoku medium: December 22, 2024
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published